• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Callan JMB Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

    3/12/26 4:01:55 PM ET
    $CJMB
    Real Estate
    Real Estate
    Get the next $CJMB alert in real time by email
    false 0002032545 0002032545 2026-03-10 2026-03-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d) OF

    THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): March 10, 2026

     

    Callan JMB Inc.

    (Exact name of registrant as specified in its charter)

     

    Nevada   001-42506   99-0931141
    (State or other jurisdiction   (Commission   (I.R.S. Employer
    of incorporation)   File Number)   Identification No.)

     

    244 Flightline Drive    
    Spring Branch, Texas   78070
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (830) 438-0395

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, $0.001 par value   CJMB   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 1.01. Entry into a Material Definitive Agreement.

     

    As previously disclosed, Callan JMB Inc., a Nevada corporation (the “Company”) entered into a Common Stock Purchase Agreement, dated as of July 24, 2025 (the “Purchase Agreement”), with Hexstone Capital, LLC (the “Investor”), pursuant to which the Company, from time to time and at its discretion, may sell shares of its common stock, par value $0.001 per share (the “Common Stock”), to the Investor, subject to certain limitations and conditions set forth in the Purchase Agreement.

     

    On March 10, 2026, the Company and the Investor entered into Amendment No. 1 to the Purchase Agreement (the “Amendment”). The Amendment modifies the Purchase Agreement as follows:

     

      ● Maturity Date. The Maturity Date has been extended to April 1, 2027.
      ● Regular Purchase Price. The Regular Purchase Price has been revised to equal 95% of the lowest daily trading price of the Common Stock during the applicable Regular Purchase Measurement Period (reduced to 75% if the Common Stock is suspended from trading or delisted from the Principal Market following the Commencement Date).
      ● Regular Purchase Measurement Period. The measurement period now begins on the day the Investor receives the applicable Purchase Notice and ends on the Trading Day on which aggregate dollar volume of Common Stock traded on the Principal Market equals five times the Purchase Amount, subject to a five Trading Day minimum. Volume calculation commences on the Trading Day immediately after the Investor receives the Pre-Settlement Regular Purchase Shares, with days on which Purchase Shares cannot be delivered or are not freely tradeable excluded from the calculation.
      ● Leak-Out Provision. The Investor’s monthly resale limitation has been revised to the greater of (a) $25,000 per Trading Day and (b) 20.0% of the daily trading volume of the Common Stock as reported by Bloomberg, L.P. on the applicable Trading Day.

     

    All other terms and conditions of the Purchase Agreement remain in full force and effect. The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

     

    The shares of Common Stock issuable under the Purchase Agreement, as amended, are registered pursuant to the Company’s effective registration statement on Form S-1 (File No. 333-289849). The Company intends to file a prospectus supplement relating to the transactions contemplated by the Amendment in accordance with the rules and regulations of the Securities and Exchange Commission.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits. The following exhibits are filed with this Form 8-K:

     

    Exhibit No.   Description
    10.1   Amendment No. 1 to Purchase Agreement, dated as of March 10, 2026, by and between Callan JMB Inc. and Hexstone Capital, LLC
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: March 12, 2026 Callan JMB Inc.
         
      By: /s/ Wayne Williams
      Name: Wayne Williams
      Title: Chief Executive Officer

     

     

    Get the next $CJMB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CJMB

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CJMB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Croyle David J bought $26,086 worth of shares (14,805 units at $1.76) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    3/10/26 7:16:06 PM ET
    $CJMB
    Real Estate

    Director Dial Gerald bought $2,409 worth of shares (2,000 units at $1.20) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    1/6/26 11:51:38 AM ET
    $CJMB
    Real Estate

    CEO, Chairman and President Williams Wayne D bought $8,650 worth of shares (5,000 units at $1.73) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    12/18/25 7:54:01 PM ET
    $CJMB
    Real Estate

    $CJMB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech's IND Clinical Trials for lodonal™ in the Treatment of Long COVID

    Callan JMB will Provide Independent Manufacturing Oversight and Governance as lodonal™ Undergoes Clinical Trials for Underserved Patient Population SPRING BRANCH, Texas, March 11, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that it has agreed with Biostax Corp d/b/a Attune Biotech Inc. ("Attune"), a clinical-stage biopharmaceutical company with a diversified therapeutic pipeline, to support its investigational new drug clinical trials for the treatment

    3/11/26 8:45:00 AM ET
    $CJMB
    Real Estate

    Callan JMB CEO, Wayne Williams Invited to Attend the 50th International GMP Conference on March 2-5, 2026

    SPRING BRANCH, Texas, March 02, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that Wayne Williams, Chief Executive Officer, Chairman & Founder, has been invited to attend the 50th International GMP Conference, on March 2-5, 2026 in Athens, Georgia. The conference is co-sponsored by the University of Georgia College of Pharmacy and U.S. Food & Drug Administration (FDA). Hosted annually since 1976, the conference offers a global forum where regulatory autho

    3/2/26 8:45:00 AM ET
    $CJMB
    Real Estate

    Callan JMB Announces Participation in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10–11, 2026

    SPRING BRANCH, Texas, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its participation in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10-11, 2026. iAccess Alpha Virtual Best Ideas Spring Investment Conference Dates: March 10–11, 2026Location: VirtualPresentation Details: Tuesday, March 10, 2026 at 10:30am ETWebcast Link: https://www.webcaster5.com/Webcast/Page/3157/53626 For more information, please contact your i

    2/27/26 8:45:00 AM ET
    $CJMB
    Real Estate

    $CJMB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Croyle David J bought $26,086 worth of shares (14,805 units at $1.76) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    3/10/26 7:16:06 PM ET
    $CJMB
    Real Estate

    Director Dial Gerald bought $2,409 worth of shares (2,000 units at $1.20) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    1/6/26 11:51:38 AM ET
    $CJMB
    Real Estate

    CEO, Chairman and President Williams Wayne D bought $8,650 worth of shares (5,000 units at $1.73) (SEC Form 4)

    4 - CALLAN JMB INC. (0002032545) (Issuer)

    12/18/25 7:54:01 PM ET
    $CJMB
    Real Estate

    $CJMB
    SEC Filings

    View All

    Callan JMB Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

    8-K - CALLAN JMB INC. (0002032545) (Filer)

    3/12/26 4:01:55 PM ET
    $CJMB
    Real Estate

    Amendment: SEC Form SCHEDULE 13G/A filed by Callan JMB Inc.

    SCHEDULE 13G/A - CALLAN JMB INC. (0002032545) (Subject)

    2/13/26 5:51:28 PM ET
    $CJMB
    Real Estate

    Callan JMB Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - CALLAN JMB INC. (0002032545) (Filer)

    1/27/26 5:10:11 PM ET
    $CJMB
    Real Estate

    $CJMB
    Leadership Updates

    Live Leadership Updates

    View All

    Callan JMB Appoints Former Assistant Commissioner of Chicago Department of Health, Christopher Shields, as Senior Vice President of Emergency Preparedness & Response/Government Affairs

    Christopher Shields, an industry veteran who oversaw operations and logistics at the city of Chicago's Emergency Preparedness and Bioterrorism program, will focus on growing Callan JMB's emergency preparedness & response operations into new U.S. cities, states, and other countries. SPRING BRANCH, Texas, April 25, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced the appointment of former Assistant Commissioner of the Chicago Department of Public Health, Christ

    4/25/25 9:00:00 AM ET
    $CJMB
    Real Estate

    $CJMB
    Financials

    Live finance-specific insights

    View All

    Callan JMB Announces Third Quarter 2025 Financial Results and Provides Business Update

    Expanded the Company's compliance-driven logistics platform into the food sampling industryEntered agreement to install oral drug delivery equipment at Texas facility Established a subsidiary in India and advanced plans for a temperature-controlled pharmaceutical storage and distribution warehouseExtended the Company's long-term contract with the City of Chicago through June 2026, including an increase in funding Upgraded Sentry Monitoring System Technology with Sentry 4 for Mobile Temperature Monitoring SPRING BRANCH, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry

    11/14/25 4:05:00 PM ET
    $CJMB
    Real Estate

    Callan JMB Announces Second Quarter 2025 Financial Results and Provides Business Update

    Formed a strategic partnership with Revival Health Inc. ("Revival") to deliver fully integrated supply chain services and infrastructure to support both the importation and onshore manufacturing of health, wellness, and longevity products Launched subsidiary in India and progressed to establish temperature-controlled warehouse for storage and distribution of pharmaceuticals at all temperature ranges Extended long-term contract with City of Chicago and received increase in funding Appointed Christopher Shields, former Assistant Commissioner of the Chicago Department of Public Health, as Senior Vice President, Emergency Preparedness & Response/Government Affairs Supported Texas and New Mex

    8/14/25 4:30:00 PM ET
    $CJMB
    Real Estate

    Callan JMB Announces Full Year 2024 Financial Results and Provides Business Update

    Successfully Closed IPO on February 6, 2025, at $4.00 per Share for Gross Proceeds of Approximately $5.7 Million, Including Partial Exercise of Over-Allotment Option SPRING BRANCH, Texas, March 28, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its financial results for the full year ended December 31, 2024, and provided a business update. "2024 was a pivotal year for Callan JMB as we continued to deliver exceptional service to our diverse client base whil

    3/28/25 5:30:00 PM ET
    $CJMB
    Real Estate